Measurable results under risk and value-based contracts.
Ascend Rx is built to move the metrics our provider and plan partners are accountable for — adherence, utilization, and total cost of care.
What changes when pharmacy is part of the care model
Coordinated pharmacy care moves the measures that determine quality performance and shared savings. Below is the impact we typically see with value-based provider partners.
| Metric | Typical impact | Why it matters |
|---|---|---|
| Medication adherence | ≥94%, a +10% to +15% improvement | Directly drives STAR Ratings, quality incentives, and bonus pools |
| STAR Ratings — medication measures | Top 5% nationally on Proportion of Days Covered | Tied directly to Medicare Advantage bonus payments and rebates |
| Hospitalizations & readmissions | Up to 20% reduction in medication-related events | Fewer adverse events from non-adherence and therapy duplication |
| Average prescriptions per member | 8% reduction | Lowers Part D cost and eliminates duplicative therapy |
| Pharmacy cost per member per month | Materially lower Rx PMPM | Improves total cost of care and medical loss ratio |
| Care team workflow | Gaps identified earlier | Real-time medication data makes outreach targeted instead of reactive |
Figures reflect results observed across value-based provider partners. Actual results vary by population, contract structure, and baseline performance.
Same patients, same market — different pharmacy
A South Florida Medicare Advantage provider group compared two groups of its own Medicare patients over a three-month period in 2024: those filling with Ascend Rx, and those using outside pharmacies. The patients served by Ascend Rx used substantially less acute care.
| Metric | Ascend Rx patients | Outside pharmacy patients | Difference |
|---|---|---|---|
| Hospital admissions per 1,000 | 47 | 228 | ↓ 79% |
| Emergency room visits per 1,000 | 140 | 410 | ↓ 66% |
| Readmission rate | 10% | 28% | ↓ 18 pts |
About this analysis. This is an observational comparison of two groups of Medicare patients within a single provider group over a three-month period in 2024. Patients were not randomly assigned, and the groups were not matched for baseline health status, so the results show a strong association rather than proving causation. We are happy to walk partners through the methodology and the underlying data in detail.
The standards we operate to
The problem these numbers are solving
Published industry research. These are not Ascend Rx results — they describe the gap our model is built to close.
Ask us to run the numbers on your population
Share a claims extract and a provider roster and we will show you where the medication-related gaps are before you commit to anything.
Call us
The fastest way to reach a member of our team.
(305) 455-1250Monday–Friday, 8:00 AM – 5:30 PM
Secure fax
For prescriptions, patient lists, and records.
(305) 655-1250Monitored during business hours.
For general and partnership inquiries only.
pharmacy@rxascend.comPlease do not send patient information by email.
Please do not email patient information. Email is not a secure way to send medication details or health records. Call us at (305) 455-1250 or use our secure fax at (305) 655-1250. If this is a medical emergency, call 911.